NCT02738554View on ClinicalTrials.gov

Off Treatment Durability in Chronic Hepatitis B With Good Immune Control

NACompletedINTERVENTIONAL
Enrollment

124

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

January 31, 2020

Study Completion Date

January 31, 2020

Conditions
Chronic Hepatitis B
Interventions
OTHER

Treatment cessation

Cessation of nucleoside analogue therapy following European Association for the Study of the Liver guidelines

Trial Locations (1)

Unknown

Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong

All Listed Sponsors
lead

The University of Hong Kong

OTHER

NCT02738554 - Off Treatment Durability in Chronic Hepatitis B With Good Immune Control | Biotech Hunter | Biotech Hunter